B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC. · Biotechnology.

Filing 2nd Quarter - Amendment

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Aug 5, 2025

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.